RETAZID 160 mg/25 mg
Valsartan / hydrochlorothiazide · film-coated tablets
About this medicine
RETAZID 160 mg/25 mg film-coated tablets is listed in Tunisia's medicine catalog under the active ingredient Valsartan / hydrochlorothiazide. This page brings together its recorded pack formats, prices and CNAM coverage information.
What is this medicine used for?
Review pending
A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.
What side effects should I know about?
Review pending
A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.
Price by pack
Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.
Pack · B/30
30 units in this pack
Recorded public price33,115 DT- AMM No.
- 9233993
- CNAM code
- 302974
- CNAM reference amount
- 32,250 DT
Price source: CNAM — Liste des médicaments remboursables · 2026-08-04
Source recorded: August 23, 2026
Price effective date not provided
Pack · B/90
90 units in this pack
Recorded public price96,820 DT- AMM No.
- 9233994
- CNAM code
- 302975
- CNAM reference amount
- 96,750 DT
Price source: CNAM — Liste des médicaments remboursables · 2026-08-04
Source recorded: August 23, 2026
Price effective date not provided
This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.
Medicine details
Medicines with matching catalog characteristics
These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.
Price source: CNAM — Liste des médicaments remboursables · 2026-08-04
Source recorded: August 23, 2026